[Enhancement of regulatory T cell induction by intravenous S-sulfonated Immunoglobulin during the treatment of experimental autoimmune encephalomyelitis]
| Autor: | Noriko Shinya, Kenshi Hayashida, Sachio Okuda, Shintaro Kamei, Satomi Harano, Takumi Sasaki |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
CD4-Positive T-Lymphocytes
Encephalomyelitis Autoimmune Experimental Regulatory T cell Encephalomyelitis Pharmaceutical Science chemical and pharmacologic phenomena Autoimmunity medicine.disease_cause T-Lymphocytes Regulatory Mice immune system diseases hemic and lymphatic diseases medicine Animals Humans IL-2 receptor Infusions Intravenous Pharmacology Autoimmune disease biology business.industry Experimental autoimmune encephalomyelitis FOXP3 hemic and immune systems medicine.disease Mice Inbred C57BL Disease Models Animal medicine.anatomical_structure Immunoglobulin G Immunology biology.protein Female Antibody business |
| Zdroj: | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 132(2) |
| ISSN: | 1347-5231 |
| Popis: | Intravenous immunoglobulin (IVIg) has been shown to be effective for a variety of autoimmune diseases. Despite its widespread use and therapeutic success, the precise mechanisms for the anti-inflammatory therapeutic effects of IVIg are not well understood. In particular, few reports have examined the mechanism of IVIg on regulatory T cells (Treg: CD4(+)CD25(+)FoxP3(+) T cells). In the present study, to clarify the effect of intravenous S-sulfonated immunoglobulin (S-IVIg) on Treg, we investigated experimental autoimmune encephalomyelitis (EAE), the representative animal model of autoimmune disease. First, when we evaluated the effect of S-IVIg in an acute EAE model, the prophylactic treatment of S-IVIg dose-dependently controlled the symptoms of EAE. Next, we measured Treg in EAE mice spleen by flow cytometry. The percentage of Treg in S-IVIg-treated mice was significantly increased compared with Saline-treated mice. Finally, in reinduced EAE, S-IVIg not only prevented EAE progression, but also increased the percentage of Treg in the spleen. The increase in percentage of Treg in S-IVIg-treated EAE might be associated with protection against EAE. These observations provide important evidence that IVIg is effective in T-cell-mediated control of autoimmunity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|